Mark Emberton, MD, PhD, of University College London. Photo courtesy of the Medical Research Council (U.K.).
Researchers in the U.K. are preparing to study whether an MRI can be used to diagnose prostate cancer in men earlier and more accurately than prostate-specific antigen (PSA) tests, which could potentially replace prostate biopsies, according to a release from the Medical Research Council in the U.K.
New research from the Washington University School of Medicine in St. Louis suggests that belly fat affects women's odds of surviving kidney cancer, but it does not impact the survival rate of men, according to an April 3 news release.
The American College of Radiology (ACR), along with more than 300 stakeholder organizations that form the Ad Hoc Group for Medical Research, exceeded its 2018 funding goals with the $1.3 trillion federal budget signed March 23 by President Donald Trump.
Eight members of the Association of University Radiologists Radiology Research Alliance Task Force on Deep Learning describe a radiologist-friendly overview examining past, present and future applications and how the field might benefit from embracing deep learning.
In 2009, the U.S. Preventative Services Task Force (USPSTF) revised its breast cancer screening guidelines. These changes may be one reason for a continuous decline in breast screening exams in the U.S. since 2010, according to results of a study published by the American Journal of Roentgenology.
Obese patients in the U.K. are getting too big to fit into MRI scanners, which can lead to health complications after canceled exams, according to a recent article by BBC News.
Penn State College of Medicine announced, April 2, the creation of a new department of radiation oncology, naming Rickhesvar Mahraj, professor of radiology and pediatrics, as its interim chair.
A team of scientists found the percentages of cancer survivors unable to afford medication or incapable of receiving care dropped each year from 2010 to 2016—during the implementation of the Affordable Care Act (ACA).
GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.
